{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:55:07Z","timestamp":1793451307063,"version":"4.5.0"},"reference-count":166,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The human respiratory and circulatory systems collaborate intricately to ensure oxygen delivery to all cells, which is vital for ATP production and maintaining physiological functions and structures. During limited oxygen availability, hypoxia-inducible factors (HIFs) are stabilized and play a fundamental role in maintaining cellular processes for hypoxia adaptation. First discovered during investigations of erythropoietin production regulation, HIFs influence physiological and pathological processes, including development, inflammation, wound healing, and cancer. HIFs promote extracellular adenosine signaling by enhancing adenosine generation and receptor signaling, representing an endogenous feedback mechanism that curbs excessive inflammation, supports injury resolution, and enhances hypoxia tolerance. This is especially important for conditions that involve tissue hypoxia, such as acute respiratory distress syndrome (ARDS), which globally poses significant health challenges without specific treatment options. Consequently, pharmacological strategies to amplify HIF-mediated adenosine production and receptor signaling are of great importance.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1328565","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T02:50:30Z","timestamp":1705632630000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Hypoxia-adenosine axis as therapeutic targets for acute respiratory distress syndrome"],"prefix":"10.3389","volume":"15","author":[{"given":"Katherine","family":"Figarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger Klaus","family":"Eltzschig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: The Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2014.08.004","article-title":"Bastarache, clinical and biological heterogeneity in ARDS: direct versus indirect lung injury","volume":"35","author":"Ciara","year":"2014","journal-title":"Clin Chest Med"},{"key":"B3","first-page":"1","article-title":"Inflammatory mechanisms in the lung","volume":"2","author":"Moldoveanu","year":"2008","journal-title":"J Inflamm Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.60.041807.123500","article-title":"Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease","volume":"61","author":"Whitsett","year":"2010","journal-title":"Annu Rev Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003571","article-title":"Acute respiratory distress syndrome: contemporary management and novel approaches during COVID-19","volume":"134","author":"Williams","year":"2021","journal-title":"Anesthesiology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000998","article-title":"Association between arterial hyperoxia and outcome in subsets of critical illness: A systematic review, meta-analysis, and meta-regression of cohort studies","volume":"43","author":"Helmerhorst","year":"2015","journal-title":"Crit Care Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for ALI and the ARDS","volume":"342","author":"Network","year":"2000","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12871-018-0631-4","article-title":"Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: A systematic review and meta-analysis","volume":"18","author":"Guo","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Gu\u00e9rin","year":"2013","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.06.032","article-title":"Treatment of ARDS with prone positioning","volume":"151","author":"Scholten","year":"2017","journal-title":"Chest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062200","article-title":"Comparison of two fluid-management strategies in acute lung injury","volume":"354","author":"Wiedemann","year":"2006","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-023-01176-y","article-title":"Hypoxia-stabilized RIPK1 promotes cell death","volume":"25","author":"Ruan","year":"2023","journal-title":"Nat Cell Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1318345110","article-title":"Hypoxia and inflammation are two sides of the same coin","volume":"110","author":"Bartels","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01633","article-title":"Purinergic signaling in pulmonary inflammation","volume":"10","author":"Le","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.604944","article-title":"Adenosine at the interphase of hypoxia and inflammation in lung injury","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3390\/biomedicines10081939","article-title":"The hypoxia-adenosine link during myocardial ischemia-reperfusion injury","volume":"10","author":"Ruan","year":"2022","journal-title":"Biomedicines"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.699069","article-title":"Editorial: purinergic signaling and inflammation","volume":"12","author":"Yuan","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0910283","article-title":"Hypoxia and inflammation","volume":"364","author":"Eltzschig","year":"2011","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr2210456","article-title":"Prolonging cellular life after hypoxic death","volume":"387","author":"Eltzschig","year":"2022","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion-from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.13.5680","article-title":"Hypoxia-inducible nuclear factors bind to an enhancer element located 3\u2032 to the human erythropoietin gene","volume":"88","author":"Semenza","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000002288","article-title":"Targeting hypoxia signaling for perioperative organ injury","volume":"126","author":"Yuan","year":"2018","journal-title":"Anesth Analg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M406026200","article-title":"Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor","volume":"279","author":"Appelhoffl","year":"2004","journal-title":"J Biol Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2012.28","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibition: Robust new target or another big bust for stroke therapeutics","volume":"32","author":"Karuppagounder","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2023.03.002","article-title":"Oxygenation target in acute respiratory distress syndrome","volume":"3","author":"Capellier","year":"2023","journal-title":"J Intensive Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1113\/JP275327","article-title":"The PHD1 oxygen sensor in health and disease","volume":"596","author":"Kennel","year":"2018","journal-title":"J Physiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.2HI1013-533R","article-title":"Prolyl-4-hydroxylase domain 3 (PHD3) is a critical terminator for cell survival of macrophages under stress conditions","volume":"96","author":"Swain","year":"2014","journal-title":"J Leukoc Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10753-022-01769-z","article-title":"Hypoxia-inducible factor 1\u03b1 and its role in lung injury: adaptive or maladaptive","volume":"46","author":"Suresh","year":"2023","journal-title":"Inflammation"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced angiogenesis: good and evil","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI84433","article-title":"Hypoxia-dependent regulation of inflammatory pathways in immune cells","volume":"126","author":"Taylor","year":"2016","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2015-0266OC","article-title":"Inhibition of prolyl hydroxylase attenuates fas ligand-induced Apoptosis and lung injury in mice","volume":"55","author":"Nagamine","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700888R","article-title":"Enhancement of glycolysis by inhibition of oxygen-sensing prolyl hydroxylases protects alveolar epithelial cells from acute lung injury","volume":"32","author":"Tojo","year":"2018","journal-title":"FASEB J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2021.03.012","article-title":"Roxadustat attenuates hyperoxia-induced lung injury by upregulating proangiogenic factors in newborn mice","volume":"62","author":"Huang","year":"2021","journal-title":"Pediatr Neonatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI77701","article-title":"HIF2\u03b1 signaling inhibits adherens junctional disruption in acute lung injury","volume":"125","author":"Gong","year":"2015","journal-title":"J Clin Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.032","article-title":"Cellular metabolism and disease: What do metabolic outliers teach us","volume":"148","author":"Deberardinis","year":"2012","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001665","article-title":"HIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epithelium","volume":"11","author":"Eckle","year":"2013","journal-title":"PloS Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002778R","article-title":"Targeting alveolar-specific succinate dehydrogenase A attenuates pulmonary inflammation during acute lung injury","volume":"35","author":"Vohwinkel","year":"2021","journal-title":"FASEB J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3390\/biomedicines10123089","article-title":"Succinate at the crossroad of metabolism and angiogenesis: roles of SDH, HIF1\u03b1 and SUCNR1","volume":"10","author":"Atallah","year":"2022","journal-title":"Biomedicines"},{"key":"B41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000853","article-title":"Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival","volume":"2","author":"Thiel","year":"2007","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.11.6140","article-title":"Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions","volume":"167","author":"Caldwell","year":"2001","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(89)90716-5","article-title":"Contribution of S-adenosylhomocysteine to cardiac adenosine formation","volume":"21","author":"Deussen","year":"1989","journal-title":"J Mol Cell Cardiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26246","article-title":"A CD38\/CD203A\/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes","volume":"2","author":"Horenstein","year":"2013","journal-title":"OncoImmunology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402132","article-title":"Adenosine, an endogenous distress signal, modulates tissue damage and repair","volume":"14","author":"Fredholm","year":"2007","journal-title":"Cell Death Differ"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-013-0999-z","article-title":"Extracellular adenosine signaling in molecular medicine","volume":"91","author":"Eltzschig","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1152\/physiol.00022.2009","article-title":"Role of extracellular adenosine in acute lung injury","volume":"24","author":"Eckle","year":"2009","journal-title":"Physiol (Bethesda Md.)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-006-9003-5","article-title":"The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance","volume":"2","author":"Robson","year":"2006","journal-title":"Purinergic Signal"},{"key":"B51","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1042\/bj2850345","article-title":"5\u2019-Nucleotidase: Molecular structure and functional aspects","volume":"285","author":"Zimmermann","year":"1992","journal-title":"Biochem J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.26.2.4650","article-title":"Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces","volume":"26","author":"Donaldson","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2638","article-title":"Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases","volume":"7","author":"Hask\u00f3","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B54","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.944994","article-title":"Alternative adenosine Receptor activation: The netrin-Adora2b link","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.837230","article-title":"Adenosine-A2A receptor pathway in cancer immunotherapy","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13046-022-02511-1","article-title":"Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist","volume":"41","author":"Bai","year":"2022","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2018.04.006","article-title":"Adenosine signaling and the immune system: When a lot could be too much","volume":"205","author":"Antonioli","year":"2019","journal-title":"Immunol Lett"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00925","article-title":"Targeting adenosine in cancer immunotherapy to enhance T-Cell function","volume":"10","author":"Vigano","year":"2019","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00304","article-title":"Extracellular adenosine-mediated modulation of regulatory T cells","volume":"5","author":"Ohta","year":"2014","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012010070","article-title":"Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection","volume":"23","author":"Kinsey","year":"2012","journal-title":"J Am Soc Nephrol: JASN"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nri2938","article-title":"Immune cell regulation by autocrine purinergic signalling","volume":"11","author":"Junger","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2405","article-title":"Autocrine adenosine regulates tumor polyfunctional CD73(+)CD4(+) effector T cells devoid of immune checkpoints","volume":"78","author":"Gourdin","year":"2018","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.106.126714","article-title":"Physiological roles of vascular nucleoside transporters","volume":"27","author":"L\u00f6ffler","year":"2007","journal-title":"Arterioscler Thrombosis Vasc Biol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"5197626","DOI":"10.1155\/2020\/5197626","article-title":"Equilibrative nucleoside transporter 2: properties and physiological roles","volume":"2020","author":"Naes","year":"2020","journal-title":"BioMed Res Int"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00101.2017","article-title":"The hypoxia-adenosine link during inflammation","volume":"123","author":"Bowser","year":"2017","journal-title":"J Appl Physiol (1985)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2728","article-title":"Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia","volume":"18","author":"Eckle","year":"2012","journal-title":"Nat Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"897","DOI":"10.4049\/jimmunol.1701414","article-title":"The hypoxia-adenosine link during intestinal inflammation","volume":"200","author":"Bowser","year":"2018","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100593","article-title":"Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury","volume":"192","author":"Eckle","year":"2014","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) and HIF-2\u03b1 in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0901326106","article-title":"Adenosine A2A receptor is a unique angiogenic target of HIF-2\u03b1 in pulmonary endothelial cells","volume":"106","author":"Ahmad","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade5111","article-title":"Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development","volume":"9","author":"Cheu","year":"2023","journal-title":"Sci Adv"},{"key":"B73","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/cells11020183","article-title":"Hypoxia-inducible factor signaling in inflammatory lung injury and repair","volume":"11","author":"Evans","year":"2022","journal-title":"Cells"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.04.012","article-title":"Hypoxia-inducible factor 1\u03b1 Signaling promotes repair of the alveolar epithelium after acute lung injury","volume":"187","author":"McClendon","year":"2017","journal-title":"Am J Pathol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01216-z","article-title":"Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation","volume":"23","author":"Mirchandani","year":"2022","journal-title":"Nat Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-012-0988-7","article-title":"Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease","volume":"91","author":"Poth","year":"2013","journal-title":"J Mol Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/ijms19041222","article-title":"Mechanisms of ATP release by inflammatory cells","volume":"19","author":"Dosch","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"H1055","DOI":"10.1152\/ajpheart.00651.2020","article-title":"Pannexin 1 channels control the hemodynamic response to hypoxia by regulating O(2)-sensitive extracellular ATP in blood","volume":"320","author":"Kirby","year":"2021","journal-title":"Am J Physiol Heart Circulatory Physiol"},{"key":"B79","first-page":"199","article-title":"Regulation of cellular ATP release","volume":"118","author":"Fitz","year":"2007","journal-title":"Trans Am Clin Climatological Assoc"},{"key":"B80","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1385\/1-59745-113-4:73","article-title":"Nucleotide metabolism and cell-cell interactions","volume":"341","author":"Eltzschig","year":"2006","journal-title":"Cell-Cell Interactions: Methods Protoc"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00414","article-title":"ATP release and purinergic signaling in NLRP3 inflammasome activation","volume":"3","author":"Gombault","year":"2012","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-165746","article-title":"Central role of Sp1-regulated CD39 in hypoxia\/ischemia protection","volume":"113","author":"Eltzschig","year":"2009","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030891","article-title":"Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: Role of ectonucleotidases and adenosine A 2B receptors","volume":"198","author":"Eltzschig","year":"2003","journal-title":"J Exp Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040915","article-title":"Crucial role for ecto-5\u2032-nucleotidase (CD73) in vascular leakage during hypoxia","volume":"200","author":"Thompson","year":"2004","journal-title":"J Exp Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cancers8010002","article-title":"Diverse mechanisms of sp1-dependent transcriptional regulation potentially involved in the adaptive response of cancer cells to oxygen-deficient conditions","volume":"8","author":"Koizume","year":"2015","journal-title":"Cancers"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45110580","article-title":"Interaction and collaboration of SP1, HIF-1, and MYC in regulating the expression of cancer-related genes to further enhance anticancer drug development","volume":"45","author":"Kimura","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s42003-021-02721-x","article-title":"Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73","volume":"4","author":"Jarvis","year":"2021","journal-title":"Commun Biol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.10.6780","article-title":"T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5\u2019-adenosine monophosphate to adenosine","volume":"177","author":"Kobie","year":"2006","journal-title":"J Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.8127","article-title":"Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury","volume":"178","author":"Eckle","year":"2007","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"277ra30","DOI":"10.1126\/scitranslmed.aaa1260","article-title":"Immunological mechanisms of the antitumor effects of supplemental oxygenation","volume":"7","author":"Hatfield","year":"2015","journal-title":"Sci Trans Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/jcp.21579","article-title":"Mechanisms of induction of adenosine receptor genes and its functional significance","volume":"218","author":"St Hilaire","year":"2009","journal-title":"J Cell Physiol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-6419com","article-title":"HIF-dependent induction of adenosine A2B receptor in hypoxia","volume":"20","author":"Kong","year":"2006","journal-title":"FASEB J"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117044","article-title":"A2B adenosine receptor dampens hypoxia-induced vascular leak","volume":"111","author":"Eckle","year":"2008","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34203","article-title":"A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice","volume":"118","author":"Eckle","year":"2008","journal-title":"J Clin Invest"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903035","article-title":"Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury","volume":"184","author":"Schingnitz","year":"2010","journal-title":"J Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401957","article-title":"Alveolar epithelial A2B adenosine receptors in pulmonary protection during acute lung injury","volume":"195","author":"Hoegl","year":"2015","journal-title":"J Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2004.11.042","article-title":"Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation","volume":"129","author":"Reece","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.2.1254","article-title":"Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury","volume":"179","author":"Reutershan","year":"2007","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.157651","article-title":"Adenosine suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production by murine macrophages through a protein kinase A- and exchange protein activated by cAMP-independent signaling pathway","volume":"331","author":"Kreckler","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2009.02.001","article-title":"Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury","volume":"37","author":"Chen","year":"2009","journal-title":"Exp Hematol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1172\/JCI170733","article-title":"Macrophage-endothelial cell crosstalk orchestrates neutrophil recruitment in inflamed mucosa","volume":"133","author":"Ren","year":"2023","journal-title":"J Clin Invest"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.05.024","article-title":"A feedback loop in PPAR\u03b3-adenosine A2A receptor signaling inhibits inflammation and attenuates lung damages in a mouse model of LPS-induced acute lung injury","volume":"25","author":"He","year":"2013","journal-title":"Cell Signal"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.06.049","article-title":"CGS 21680, an agonist of the adenosine (A 2A) receptor, decreases acute lung inflammation","volume":"668","author":"Impellizzeri","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050177","article-title":"HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia","volume":"202","author":"Eltzschig","year":"2005","journal-title":"J Exp Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.037","article-title":"Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia","volume":"136","author":"Morote-Garcia","year":"2009","journal-title":"Gastroenterology"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-228551","article-title":"Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury","volume":"27","author":"Eckle","year":"2013","journal-title":"FASEB J"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.636678","article-title":"Enhancing extracellular adenosine levels restores barrier function in acute lung injury through expression of focal adhesion proteins","volume":"8","author":"Wang","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.121521","article-title":"Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation","volume":"3","author":"Aherne","year":"2018","journal-title":"JCI Insight"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166011","article-title":"Targeting myocardial equilibrative nucleoside transporter ENT1 provides cardioprotection by enhancing myeloid Adora2b signaling","volume":"8","author":"Ruan","year":"2023","journal-title":"JCI Insight"},{"key":"B111","doi-asserted-by":"publisher","first-page":"14108","DOI":"10.1038\/ncomms14108","article-title":"Erythrocytes retain hypoxic adenosine response for faster acclimatization upon re-ascent","volume":"8","author":"Song","year":"2017","journal-title":"Nat Commun"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-126763","article-title":"HIF-l-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak","volume":"111","author":"Morote-Garcia","year":"2008","journal-title":"Blood"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140300","article-title":"Hypoxia-inducible factor-1alpha-dependent induction of miR122 enhances hepatic ischemia tolerance","volume":"131","author":"Ju","year":"2021","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1124\/pr.119.019026","article-title":"Strategies to modulate microRNA functions for the treatment of cancer or organ injury","volume":"72","author":"Lee","year":"2020","journal-title":"Pharmacol Rev"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005146","article-title":"The role of microRNAs in acute respiratory distress syndrome and sepsis, from targets to therapies: A narrative review","volume":"131","author":"Lee","year":"2020","journal-title":"Anesth Analg"},{"key":"B116","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.freeradbiomed.2013.05.022","article-title":"Hypoxia: A master regulator of microRNA biogenesis and activity","volume":"64","author":"Nallamshetty","year":"2013","journal-title":"Free Radical Biol Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biochi.2017.10.027","article-title":"Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma","volume":"146","author":"Wang","year":"2018","journal-title":"Biochimie"},{"key":"B118","doi-asserted-by":"publisher","first-page":"846501","DOI":"10.1155\/2015\/846501","article-title":"MicroRNA-146b-3p regulates retinal inflammation by suppressing adenosine deaminase-2 in diabetes","volume":"2015","author":"Fulzele","year":"2015","journal-title":"BioMed Res Int"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01276-10","article-title":"MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia","volume":"31","author":"Bruning","year":"2011","journal-title":"Mol Cell Biol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/gutjnl-2011-300012","article-title":"Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis","volume":"61","author":"Aherne","year":"2012","journal-title":"Gut"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e3283514bd0","article-title":"Hypoxia signaling during intestinal ischemia and inflammation","volume":"18","author":"Grenz","year":"2012","journal-title":"Curr Opin Crit Care"},{"key":"B122","doi-asserted-by":"publisher","first-page":"R189","DOI":"10.1186\/cc9301","article-title":"The neuronal guidance protein netrin-1 reduces alveolar inflammation in a porcine model of acute lung injury","volume":"14","author":"Mutz","year":"2010","journal-title":"Crit Care"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319313","article-title":"Silencing myeloid netrin-1 induces inflammation resolution and plaque regression","volume":"129","author":"Schlegel","year":"2021","journal-title":"Circ Res"},{"key":"B124","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.1683","article-title":"Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia","volume":"10","author":"Rosenberger","year":"2009","journal-title":"Nat Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002407R","article-title":"Hypoxia-inducible factor-dependent induction of myeloid-derived netrin-1 attenuates natural killer cell infiltration during endotoxin-induced lung injury","volume":"35","author":"Berg","year":"2021","journal-title":"FASEB J"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201700219R","article-title":"HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis","volume":"31","author":"Philip","year":"2017","journal-title":"FASEB J"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1165\/rcmb.2004-0103OC","article-title":"Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts","volume":"32","author":"Zhong","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3390\/molecules201119717","article-title":"Recent advances in developing inhibitors for hypoxia-inducible factor prolyl hydroxylases and their therapeutic implications","volume":"20","author":"Kim","year":"2015","journal-title":"Molecules"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000527835","article-title":"Updates on hypoxia-inducible factor prolyl hydroxylase inhibitors in the treatment of renal anemia","volume":"9","author":"Li","year":"2023","journal-title":"Kidney Dis (Basel)"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa149","article-title":"Hypoxia response and acute lung and kidney injury: Possible implications for therapy of COVID-19","volume":"13","author":"Del Vecchio","year":"2020","journal-title":"Clin Kidney J"},{"key":"B131","unstructured":"NCT04463602, Desidustat in the Management of COVID-19 Patients2020"},{"key":"B132","unstructured":"NCT04478071, Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)2020"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2066","article-title":"Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: Coordination by extracellular nucleotide metabolism","volume":"104","author":"Eltzschig","year":"2004","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00243.2007","article-title":"Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia","volume":"293","author":"Grenz","year":"2007","journal-title":"Am J Physiol - Renal Physiol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00886-y","article-title":"Interplay of hypoxia-inducible factors and oxygen therapy in cardiovascular medicine","volume":"20","author":"Liang","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030174","article-title":"Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury","volume":"3","author":"Thiel","year":"2005","journal-title":"PloS Biol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0180OC","article-title":"Pulmonary natural killer T cells play an essential role in mediating hyperoxic acute lung injury","volume":"48","author":"Nowak-Machen","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1517\/13543784.14.7.797","article-title":"Adenosine A2A agonists in development for the treatment of inflammation","volume":"14","author":"Lappas","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0607359","article-title":"A2A receptors in inflammation and injury: lessons learned from transgenic animals","volume":"83","author":"Hask\u00f3","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2005.12.056","article-title":"Adenosine in the airways: Implications and applications","volume":"533","author":"Spicuzza","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.01.094","article-title":"Pharmacological characterisation and inhibitory effects of (2R,3R,4S,5R)-2-(6-amino-2-{[(1S)-2-hydroxy-1-(phenylmethyl)ethyl]amino} -9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol, a novel ligand that demonstrates both adenosine A2A receptor agonist and adenosine A3 receptor antagonist activity","volume":"564","author":"Bevan","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1365-2222.2006.02546.x","article-title":"Targeting adenosine receptors in the treatment of allergic rhinitis: A randomized, double-blind, placebo-controlled study","volume":"37","author":"Rimmer","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"B143","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1398-9995.2007.01557.x","article-title":"Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response","volume":"63","author":"Luijk","year":"2008","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-015-0387-x","article-title":"ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers","volume":"23","author":"Henzlova","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.nuclcard.2008.02.009","article-title":"Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial","volume":"15","author":"Leaker","year":"2008","journal-title":"J Nucl Cardiol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-012-9547-4","article-title":"A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease","volume":"19","author":"Prenner","year":"2012","journal-title":"J Nucl Cardiol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.nuclcard.2008.02.013","article-title":"Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial)","volume":"15","author":"Thomas","year":"2008","journal-title":"J Nucl Cardiol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-228122","article-title":"Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A2A dependent","volume":"27","author":"Konrad","year":"2013","journal-title":"FASEB J"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-6618(03)00002-1","article-title":"The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat","volume":"47","author":"Abdel-Salam","year":"2003","journal-title":"Pharmacol Res"},{"key":"B151","article-title":"Pentoxifylline suppression of tumor necrosis factor gene transcription","volume":"110","author":"Doherty","year":"1991","journal-title":"Surgery"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.1.391","article-title":"Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin\/tumor necrosis factor synthesis at separate points in the signaling pathway","volume":"172","author":"Han","year":"1990","journal-title":"J Exp Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"A292","DOI":"10.1136\/jitc-2020-SITC2020.0476","article-title":"476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19","volume":"8","author":"Zhong","year":"2020","journal-title":"BMJ Specialist Journals"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.847894","article-title":"Role of CD39 in COVID-19 severity: dysregulation of purinergic signaling and thromboinflammation","volume":"13","author":"D\u00edaz-Garc\u00eda","year":"2022","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30805","article-title":"Alterations in CD39\/CD73 axis of T cells associated with COVID-19 severity","volume":"237","author":"Dorneles","year":"2022","journal-title":"J Cell Physiol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239692","article-title":"Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia","volume":"15","author":"Correale","year":"2020","journal-title":"PloS One"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.676577","article-title":"Case report: can inhaled adenosine attenuate COVID-19","volume":"12","author":"Spiess","year":"2021","journal-title":"Front Pharmacol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00085","article-title":"Regulation of inflammation by adenosine","volume":"4","author":"Hask\u00f3","year":"2013","journal-title":"Front Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29125","article-title":"New insights into the regulation of inflammation by adenosine","volume":"116","author":"Linden","year":"2006","journal-title":"J Clin Invest"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1002\/med.2610120502","article-title":"Adenosine A1 and A2 receptors: structure\u2013function relationships","volume":"12","author":"van Galen","year":"1992","journal-title":"Medicinal Res Rev"},{"key":"B161","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/s41467-021-22179-z","article-title":"Adenosine integrates light and sleep signalling for the regulation of circadian timing in mice","volume":"12","author":"Jagannath","year":"2021","journal-title":"Nat Commun"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.20411.1","article-title":"Recent advances in the understanding and management of ARDS","volume":"8","author":"Peck","year":"2019","journal-title":"F1000Research"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000420","article-title":"Guidelines on the management of acute respiratory distress syndrome","volume":"6","author":"Griffiths","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"B164","doi-asserted-by":"publisher","first-page":"200317","DOI":"10.1183\/16000617.0317-2020","article-title":"Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research","volume":"30","author":"Bos","year":"2021","journal-title":"Eur Respir Rev"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm5755","article-title":"Endothelial FoxM1 reactivates aging-impaired endothelial regeneration for vascular repair and resolution of inflammatory lung injury","volume":"15","author":"Huang","year":"2023","journal-title":"Sci Trans Med"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001525","article-title":"Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review","volume":"10","author":"Ragel","year":"2023","journal-title":"BMJ Open Respir Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1328565\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T02:50:39Z","timestamp":1705632639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1328565\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":166,"alternative-id":["10.3389\/fimmu.2024.1328565"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1328565","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,19]]},"article-number":"1328565"}}